HRT Financial’s 20/20 Biolabs AIDX Stock Holding History
Bought
Maintained
Sold
Other funds holding AIDX
HRT Financial's AIDX Position: Q3 2026 in Review
HRT Financial reduced its 20/20 Biolabs (AIDX) stake by 83% in Q3 2026, selling an estimated $38.4K and leaving 14,869 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #4587.
HRT Financial first reported a position in AIDX in Q2 2026 and has held it in 2 quarters since. The position peaked at $49K in Q2 2026. 16 funds tracked by Wall St. Rank hold AIDX as of Q3 2026.
- HRT Financial held 14,869 shares of 20/20 Biolabs worth $6K as of Q3 2026.
- HRT Financial sold 74,404 20/20 Biolabs shares in Q3 2026, an estimated $38.4K.
- 20/20 Biolabs made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4587 holding.
- HRT Financial first reported a position in 20/20 Biolabs in Q2 2026 and has held it in 2 quarters since.
- HRT Financial's 20/20 Biolabs position peaked at $49K in Q2 2026.
- 16 funds tracked by Wall St. Rank held 20/20 Biolabs as of Q3 2026.
Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.